Last Updated 2006/12/11

 
Recent studies on the extracellular matrix have revealed not only its static function to merely support cells but also its dynamic function to regulate cell behaviors by storing and distributing signaling molecules and growth factors. Thus, importance of the matrix as microenvironment for the cell has been recognized by various research fields including development, cancer, and tissue engineering. On the other hand, recent advances in carbohydrate researches have demonstrated specific function of carbohydrates.
The aim of this international symposium, entitled "Extracellular Glycomatrix", is to connect both fields toward further understanding of the structure and function of the extracellular matrix, especially focusing on carbohydrate molecules such as hyaluronan and proteogylcans.
June 15 (Thu) - 17 (Sat), 2006

The Hyogo Prefectural Awaji Yumebutai International Conference Center
1 Yumebutai, Awaji Island, Hyogo 656-2306 Japan
TEL:81-799-74-1020
FAX:81-799-74-1021

E-mail: otoiawase@yumebutai.co.jp
URL: http://www.yumebutai.org/conf_e/index.html

"Extracellular Glycomatrix in Health and Disease" Organizing Committee
Chair Person of the Organizing Committee: Koji Kimata (Institute for Molecular Science of Medicine, Aichi Medical University)
Organizing Committee
Chairman:
Koji Kimata (Institute for Molecular Science of Medicine, Aichi Medical University)
Members:
Hisashi Iwata(Nagoya Kyouritsu Hospital)
Masahiko Endo(Hirosaki University )
Nobuo Kato(Aichi Medical University)
Hidehiko Saito(National Hospital Organization Nagoya Medical Center)
Masayuki Miyasaka(Osaka University)
Takashi Muramatsu(Aichi Gakuin University)
Masaki Yanagishita (Tokyo Medical and Dental University)
Scientific Committee
Chairman:
Masaki Yanagishita (Tokyo Medical and Dental University)
Vincent C. Hascall (The Cleveland Clinic Foundation)
Standing board members:
Naoki Itano (Shinshu University)
Tamayuki Shinomura (Tokyo Medical and Dental University)
Kazuyuki Sugahara(Kobe Pharmaceutical University)
Osami Habuchi(Aichi University of Education)
Masahiko Yoneda (Aichi Prefectural College of Nursing & Health)
Hideto Watanabe (Institute for Molecular Science of Medicine, Aichi Medical University)
Members: Masayuki Ishihara (National Defense Medical College )
Atsuhiko Oohira ( Aichi Human Service Center)
Minoru Okayama (Kyoto Sangyo University)
Haruko Ogawa (Ochanomizu University)
Kayoko Oguri (Nagoya National Hospital)
Reiji Kannagi (Aichi Cancer Center)
Keiichi Takagaki(Hirosaki University )
Toshihiko Toida (Chiba University)
Teruo Nishida (Yamaguchi University)
Eri Hirasawa (Juntendo University)
Nobuaki Maeda (Tokyo Metropolitan Institute for Neuroscience)
Advisory Board
Torvard Laurent (Uppsala University)
Ulf Lindahl (Uppsala University)
Dick Heinegard (Lund University)
Bryan Toole (Tufts University)
Tim Hardingham (University of Manchester)
Jeffrey Esko (University of California)
Yoshihiko Yamada (NIH)
Guido David (Katholieke Universiteit Leuven)
Alan Rapraeger (University of Wisconsin)
Date: June 15(Thu), 2006
Session 1 “Biosynthesis, Structure, and Degradation-1”
Chairperson
Vincent C. Hascall (Lerner Research institute, Cleveland Clinic Foundation)
09:00-09:25
Vincent C. Hascall
Special Lecture : "Inter-alpha-Trypsin-Inhibitor and Hyaluronan: Partners that SHAPe Inflammation"
09:25-09:50
Bruce Caterson
(Connective Tissue Biology Research Group, Cardiff School of Biosciences, Cardiff University)
“Chondroitin Sulphate sulphation motifs as potential biomarkers for isolation of Stem/Progenitor Cells”
09:50-10:15 Hisashi Narimatsu
(National Institute of Advanced Industrial Science and Technology)
"CS synthases as members of 3GT and 4GT glycosyltransferases"
10:15-10:40 Osami Habuchi
(Department of Chemistry, Aichi University of Education)
"Functional roles of N-linked oligosaccharides attached to sulfotransferases involved in the formation of divergent structures of chondroitin sulfate"
10:40-11:00 COFFEE BREAK
11:00-11:25 Paul H. Weigel
(Department of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center)
"HARE/Stab-2 binds and mediates the uptake and degradation of multiple glycosaminoglycans"
11:25-11:50 John E. Scott
(Chemical Morphology, Medical School, Manchester University)
"Our elastic shape is held together by carbohydrate strings. Implications for the aetiology of osteoarthrosis"
11:50-13:00 POSTER SESSION / LUNCH
Session 2 “Biosynthesis, Structure, and Degradation-2”
Chairperson
Ulf Lindahl (Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University)
Masaki Yanagishita (Division of Bio-Matrix, Tokyo Medical and Dental University)
13:00-13:25 Ulf Lindahl
(Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University)
"Heparan sulfate - what will work and what will not? "
13:25-13:50 Marion Kusche-Gullberg
(Section of Physiology, Department of Biomedicine, University of Bergen)
"EXT1 and EXT2 proteins and heparan sulfate biosynthesis"
13:50-14:15 Kazuyuki Sugahara
(Graduate School of Life Science, Hokkaido University)
"Functions of chondroitin sulphate / dermatan sulphate in the brain development: Critical roles of E and/or iE disaccharide units recognized by a specific antibody"
14:15-14:45 COFFEE BREAK
14:45-15:10 Masaki Yanagishita
(Division of Bio-Matrix, Tokyo Medical and Dental University)
"Endocytosis and intracellular degradation of cell surface heparan sulfate proteoglycans"
15:10-15:35 Anders Malmstrom
(Lunds University, Department of Experimental Medical Science)
“Identification of Dermatan Sulfate Epimerases”
15:35-15:55 Yoshimitsu Kakuta
(Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Kyushu University)
"Study of capsule synthetic enzyme of E. coli"
15:55-19:00 POSTER SESSION
Session 3 “Signal Transduction”
Chairperson
Alan C. Rapraeger (Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison)
Nobuaki Maeda (Department of Molecular Developmental Biology, Tokyo Metropolitan Institute for Neuroscience)
19:00-19:25 Alan C. Rapraeger
(Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison)
“Regulation of alphaVbeta3 and alphaVbeta5 integrins by syndecan-1 in tumor cell adhesion and angiogenesis”
19:25-19:50 Guido David
(Department of Human Genetics, University of Leuven and Flanders Interuniversity Institute for Biotechnology)
"Syndecan-assisted endocytic trafficking"
19:50-20:15 John R. Couchman
(Division of Biomedical sciences, Faculty of Medicine, Imperial College London)
"A ROCK and role for syndecans in cytoskeletal regulation"
20:15-20:30 Nobuaki Maeda
(Department of Molecular Developmental Biology, Tokyo Metropolitan Institute for Neuroscience)
"PTPzeta signaling and neural network formation"
20:30-20:45 Eri Hirasawa
(Juntendo University School of Medicine)
"Role of perlecan as a modulator in neuromuscular signaling"
20:45-21:00 Haruko Ogawa
(Graduate School of Humanities and Sciences and The Glycoscience Institute, Ochanomizu University)
"Reactivity and utility of pseudoproteoglycan probes that simulate proteoglycan supramolecular structure"
 
Date: June 16(Fri), 2006
Session 4 “Development, KO”
Chairperson
Lena Kjellen (Department of Medical Biochemistry and Microbiology, Uppsala University, BMC)
Yu Yamaguchi (Developmental Neurology, The Burnham Institute)
08:40-09:05
Lena Kjellen
(Department of Medical Biochemistry and Microbiology, Uppsala University, BMC)
"Heparan sulfate biosynthesis: Interaction partners of the NDST enzymes"
09:05-09:30
Yoshihiko Yamada
(Division of Intramural Research, the National Institute of Dental and Craniofacial Research, the National Institutes of Health)
"Multiple functions of perlecan in development and diseases"
09:30-09:55 Yu Yamaguchi
(Developmental Neurology, The Burnham Institute)
"Heparan sulfate as a master regulator of morphogenetic signaling"
09:55-10:20 Scott B. Selleck
(Department of Pediatrics, Developmental Biology Center, University of Minnesota )
"Understanding heparan sulfate proteoglycan function in tissue assembly using two model systems, the fruitfly Drosophila and the zebrafish Danio rerio"
10:20-10:40 COFFEE BREAK
10:40-11:00 Hiroshi Nakato
(Department of Genetics, Cell Biology and Development, The University of Minnesota )
"Molecular mechanisms of Glypican co-receptor function: The role of drosophila dally in Dpp signaling"
11:00-11:25 Takashi Muramatsu
(Department of Health Science, Faculty of Psychological and Physical Sciences, Aichi Gakuin University)
"Midkine is important in neurogenesis and is recognized both by chondroitin sulfate proteoglycans and heparan sulfate proteoglycans"
11:25-11:50 Atsuhiko Oohira
(Institute for Developmental Research, Aichi Human Service Center)
"Multiple biological activities of neuroglycan C, a central nervous system-specific chondroitin sulfate proteoglycan"
Session 5 “Special Lecture”
Chairperson
Minoru Okayama (Faculty of Engineering, Kyoto Sangyo University)
11:50-12:30 Koji Kimata
(Institute for Molecular Science of Medicine, Aichi Medical University)
"From proteoglycans to the enzymes"
12:30-13:30 LUNCH
13:30-18:00 EXCURSION (Naruto Uzusio [whirling waves] Cruising)
19:00-21:00 BANQUET (The Westin Awaji Banquet Hall Stella)
 
Date: June 17(Sat), 2006
Session 6 “Hyaluronan and Cell Interaction”
Chairperson
Bryan P. Toole (Department of Cell Biology and Anatomy, Medical University of South Carolina)
Naoki Itano (Institute on Aging and Adaptation, Graduate School of Medicine, Shinshu University)
09:00-09:25
Bryan P. Toole
(Department of Cell Biology and Anatomy, Medical University of South Carolina)
"Hyaluronan: An essential partner in oncogenic pathways and multidrug resistance"
09:25-09:50
Warren Knudson
(The Department of Anatomy and Cell Biology, East Carolina University)
"Regulation of CD44 hyaluronan receptor function by protein acylation"
09:50-10:15 Anthony J. Day
(Faculty of Life Sciences, University of Manchester)
"Hyaluronan-protein interactions in inflammatory processes"
10:15-10:35 COFFEE BREAK
10:35-10:50 Kazuki Sugahara
(Burnham Institute for Medical Research)
"Hyaluronan-CD44 interactions and tumor progression"
10:50-11:05 Toshihiko Toida
(Faculty of Pharmaceutical Sciences, Chiba University)
"Metabolic fate of orally administered hyaluronan"
11:05-11:20 Naoki Itano
(Institute on Aging and Adaptation, Graduate School of Medicine, Shinshu University)
"The role of hyaluronan in tumor angiogenesis."
11:20-11:35 Ikuko Kakizaki
(Hirosaki University School of Medicine)
"Applied research on inhibitor of hyaluronan synthesis "
11:35-12:35 LUNCH
Session 7 “Matrix Formation and Diseases”
Chairperson
James H. Kimura (Development of Surgery, John A. Burns School of Medicine, University of Hawaii at Manoa)
12:35-13:00 Dick K. Heinegård
(Department of Cell and Molecular Biology, Lund University)
"Posttranslational modifications of extracellular matrix molecules add functional properties"
13:00-13:25 Timothy E. Hardingham
(UK Centre for Tissue Engineering at The Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Science, University of Manchester)
"Making matrix: Early signals in chondrogenesis of human adult stem cells"
13:25-13:50 James Kimura
(Development of Surgery, John A. Burns School of Medicine, University of Hawaii at Manoa)
"Alterations in Extracellular Matrix Gene Expression During Chondrocyte Dedifferentiation Detected with DNA Gene Expression Arrays"
13:50-14:10 Hideto Watanabe
(Institute for Molecular Science of Medicine, Aichi Medical University)
"In vivo function of versican/PG-M: analysis of knockin mice"
14:10-14:25 COFFEE BREAK
14:25-14:50 Thomas N. Wight
(Benaroya Research Institute at Virginia Mason)
"Hyaluronan and versican (PGM): Partners in crime in vascular disease"
14:50-15:15 Roberto Perris
(Department of Evolutionary and Functional Biology, University of Parma)
"NG2 proteoglycan acts as a master regulator of tumour progression"
15:15-15:40 Kayoko Oguri
(Clinical Research Center, National Hospital Organization Nagoya Medical Center)
"Functional analysis of cell surface heparan sulfate proteoglycans as modulators of MMPs"
15:40-16:00 Prachya Kongtawelert
(Department of Biochemistry, Faculty of Medicine, Chiang Mai University)
"WF6: a CS monoclonal antibody and its application in monitoring joint pathology in vitro and in vivo"